Drugs / IL-12 transduced TIL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01236573 | Oct 2010 → Mar 2015 | metastatic melanoma, skin cancer | National Institutes of Health Clinical Center (CC) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-12 transduced TIL | “Biological: IL-12 transduced TIL” NCT01236573 ↗ |
| Route | Intravenous | “cells will be infused intravenously (i.v.)” NCT01236573 ↗ |